Quang X. Pham, Chairman and CEO, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 7,400 shares at $3.03 ($22K) on 2026-06-29, disclosed to the SEC on 2026-07-01.
Scheduled sale ($22k) by Chairman and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |
| CVKD | SELL | 2026-06-10 | $93K | — | Filing → |